Antibiotic treatment for urinary tract infections in pediatric patients

Minerva Pediatrica

Volumn 55, Issue 5, 2003, Pages 395-406

  Hellerstein, S ^a,b  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b CHILDREN S MERCY HOSPITAL   (United States)

Author keywords

Antibiotics; Child; Urinary tract infections

Indexed keywords

AMOXICILLIN; AMPICILLIN; CEFALEXIN; CEFIXIME; CEFOTAXIME; CEFPODOXIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN; GENTAMICIN; LORACARBEF; NITROFURANTOIN; SULFAFURAZOLE; SULFAMETHOXAZOLE; TRIMETHOPRIM;

ACCURACY; CLINICAL TRIAL; ESCHERICHIA COLI; HOSPITALIZATION; HUMAN; PATHOGENESIS; PYELONEPHRITIS; REVIEW; TREATMENT OUTCOME; URINARY TRACT INFECTION; URINE CULTURE;

ACUTE DISEASE; ADMINISTRATION, ORAL; ADOLESCENT; AGE FACTORS; AMOXICILLIN; ANTI-BACTERIAL AGENTS; ANTI-INFECTIVE AGENTS, URINARY; CEFOTAXIME; CEFTRIAXONE; CEPHALOSPORINS; CHILD; CHILD, PRESCHOOL; CYSTITIS; GENTAMICINS; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; INJECTIONS, INTRAVENOUS; OUTPATIENTS; PYELONEPHRITIS; TIME FACTORS; URINARY TRACT INFECTIONS;

EID: 0345304382     PISSN: 00264946     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (50)

1. Jodal U. The periurethral flora and UTI. Dialog Pediatr Urol 1998;21:2-3.
2. Lidefelt KJ, Bollgren I, Nord CE: Changes in periurethral microflora after antimicrobial drugs. Arch Dis Child 1991;66:683-5.
3. Stamm WE. Prevention of urinary tract infections. Am J Med 1984;76:148-54.
4. Brumfitt W, Gargan RA, Hamilton-Miller JMT. Periurethral enterobacterial carriage preceding urinary infection. Lancet 1987;1:824-6.
5. Wiswell TE. The prepuce, urinary tract infections, and the consequences. Pediatrica 2000;105:860-2.
6. Roberts JA, Suarez GM, Kaack B, Kallenius G, Svenson S. Experimental pyelonephritis in the monkey. VII. Ascending pyelonephritis in the absence of vesicoureteral reflux. J Urol 1985;133:1068-75.
7. Hellerstein S. Urinary tract infections: old and new concepts. Pediatr Clin North Am 1995;42:1433-57.
8. Cain MP. Etiololgy, diagnosis and management of non-reflux pyelonephritis. Dialog Pediatr Urol 1996;19:1-8.
9. Källenius G, Svenson SB, Hultberg H, Möllby R, Winberg J, Roberts JA. P-fimbriae of pyelonephritogenic Escherichia coli: significance for reflux and renal scarring a hypothesis. Infection 1983;11:73-6.
10. Wettergren B, Jodal U. Spontaneous clearance of asymptomatic bacteriuria in infants. Acta Paediatr Scand 1990;79:300-4.
11. Loberant N, Jerushalmi J, Camal S, Gaitini D, Greif Z, Noi I. Acute focal bacterial nephritis: emphasis on imaging. Child Nephrol Urol 1990;10:150-3.
12. Rathore MH, Barton LL, Luisiri A. Acute lobar nephronia: a review. Pediatrics 1991;87:728-34.
13. Kass EH. Bacteriuria and the diagnosis of infections of the urinary tract. Arch Intern Med 1957;100:709-14.
14. Boshell BR, Sanford JP. A screening method for the evaluation of urinary tract infections in female patients without catheterization. Ann Intern Med 1958;48:1040-5.
15. Pryles CV, Lüders D, Alkan MK. A comparative study of bacterial cultures and colony counts in paired specimens of urine obtained by catheter versus voiding from normal infants and infants with urinary tract infection. Pediatrics 1961;27:17-28.
16. Stamm WE, Wagner KF, Amsel R, Alexander ER, Turck M, Counts GW et al. Causes of the acute urethral syndrome in women. N Engl J Med 1980;303:409-15.
17. Fairley KF, Birch DF. Detection of bladder bacteriuria in patients with acute urinary symptoms. J Infect Dis 1989;159:226-31.
18. Hansson S, Brandström P, Jodal U, Larsson P. Low bacterial counts in infants with urinary tract infection. J Pediatr 1998;132:180-2.
19. Hellerstein S. Urinary tract infections in children: pathophysiology, risk factors, and management. Infect Med 2002:554-60.
20. Hellerstein S. Urinary tract infections: old and new concepts. Pediatr Clin North Am 1995;42:1433-57.
21. Baraff LJ, Oslund SA, Schriger DL, Stephen ML. Probability of bacterial infections in febrile infants less than three months of age: a meta-analysis. Pediatr Infect Dis J 1992;11:257-65.
22. Byington CL, Rittichier KK, Bassett KA, Castillo H, Glasgow TS, Daly J et al. Serious bacterial infections in febrile infants younger than 90 days of age: the importance of ampicillin-resistant pathogens. Pediatrics 2003;111:964-8.
23. Carapetis JR, Jaquiery AL, Buttery JP, Starr M, Cranswich NE, Kohn S et al. Randomized, controlled trial comparing once daily and three times daily gentamicin in children with urinary tract infections. Pediatr Infect Dis J 2001;20:240-6.
24. Chong CY, Tan AL, Tan-Kendrick A, Balakrishnan A, Chao SM. Treatment of urinary tract infection with gentamicin once or three times daily. Paediatr 2003;92:291-6.
25. Nowrouzian F, Hesselmar B, Saalman R, Strannegard IL, Aberg N, Wold AE et al. Escherichia coli in infants' intestinal microflora:colonization rate, strain turnover, and virulence gene carriage. Pediatr Res 2003;54:8-14.
26. Allen UD, MacDonald N, Fuite L, Chan F, Stephens D. Risk factors for resistance to "first-line" antimicrobials among urinary tract isolates of Escherichia coli in children. Care Med Assoc J 1999;160:1436-40.
27. Gordon KA, Jones RN, SENTRY Participant Groups. Susceptibility patterns of orally administered antimicrobials among urinary tract infection pathogens from hospitalized patients in North America: comparison report to Europe and Latin America. Results from the SENTRY Antimicrobial Surveillance Program (2000). Diagn Microbiol Infect Dis 2003;45:295-301.
28. Ladhani S, Gransden W. Increasing antibiotic resistance among urinary tract isolates. Arch Dis Child 2003;88:444-5.
29. Allen S, Alon U, Blowey D, Hellerstein S, Kaplan RA, Warady BA. Follow-up urine cultures in patients with acute pyelonephritis. Pediatr Infect Dis 1993;12:170-1.
30. Schaad UB, Eskola J, Kafetzis D, Fishbach M, Ashkenazis S, Syriopoulou V et al. Cefepime vs ceftazidime treatment of pyelonephritis: a European, randomized, controlled study of 300 pediatric cases. Pediatr Infect Dis J 1998;17:639-44.
31. Hoberman A, Wald ER, Hickey RW, Baskin M, Charron M, Majd M et al. Oral versus initial intravenous therapy for urinary tract infections in young febrile children. Pediatrics 1999;104:79-86.
32. Practice parameter: the diagnosis, treatment, and evaluation of the initial urinary tract infection in febrile infants and young children. American Academy of Pediatrics. Committee on Quality Improvement. Subcommittee on Urinary Tract Infection. Pediatrics 1999;103(4 Pt 1):843-52.
33. Benador D, Neuhaus TJ, Papazyan JP, Willi UV, Engel-Bicik I, Nadal D et al. Randomised controlled trial of three day versus 10 day intravenous antibiotics in acute pyelonephritis: effect on renal scarring. Arch Dis Child 2001;84:241-6.
34. Baker PC, Nelson DS, Schunk JE. The addition of ceftriaxone to oral therapy does not improve outcome in febrile children with urinary tract infections. Arch Pediatr Adolesc Med 2001;155:135-9.
35. Glauser MP, Lyons JM, Braude AI. Prevention of chronic experimental pyelonephritis by suppression of acute suppuration. J Clin Invest 1978;61:403-7.
36. Glauser MP, Meylan P, Bille J. The inflammatory response and tissue damage. Pediatr Nephrol 1987;1:615-22.
37. Winberg J, Bollgren I, Källenius MD, Möllby R, Svenson SB. Clinical pyelonephritis and focal renal scarring. Pediatr Clin North Am 1982;29:801-14.
38. Smellie JM, Ransley PG, Normand ICS, Prescod N, Edwards D. Development of new renal scars: a collaborative study. Br Med J 1985;290:1960.
39. Honkinen O, Jahnukainen T, Mertsola J, Eskola J, Ruuskanen O. Bacteremic urinary tract infection in children. Pediatr Infect Dis 2000;19:630-4.
40. Kline MW, Kaplan SL, Baker CJ. Acute focal bacterial nephritis: diverse clinical presentations in pediatric patients. Pediatr Infect Dis J 1988;7:346-9.
41. Bajaj JK, Karyakarte RP, Kulkarni JD, Deshmukh AB. Changing aetiology of urinary tract infections and emergence of drug resistance as a major problem. J Commun Dis 1999;31:181-4.
42. Prais D, Straussberg R, Avitzur Y, Nussinovitch M, Harel L, Amir J. Bacterial susceptibility to oral antibiotics in community acquired urinary tract infection. Arch Dis Child 1988;3:215-8.
43. Nicolle L. Best pharmacological practice: urinary tract infections. Expert Opin Pharmacother 2003;4:693-704.
44. Tran D, Muchant D, Aronoff SC. Short-course versus conventional length antimicrobial therapy for uncomplicated lower urinary tract infections in children: a meta-analysis of 1 279 patients. J Pediatr 2001;139:93-9.
45. Michael M, Hodson EM, Craig JC, Martin S, Moyer VA. Short compared with standard duration of antibiotic treatment for urinary tract infection: a systematic review of randomised controlled trials. Arch Dis Child 2002;2002:118-23.
46. Keren R, Chan E. A meta-analysis of randomized, controlled trials comparing short- and long-course antibiotic therapy for urinary tract infections in children. Pediatrics 2002;109:70.
47. Warren JW, Abrutyn E, Hebel JR, Johnson JR, Schaeffer AJ, Stamm WE. Guidelines for antimicrobial treatment of uncomplicated acute bacterial cystitis and acute pyelonephritis in women. Clin Infect Dis 1999;29:745-58.
48. Marks MI, Arrieta AC. Genitourinary tract infections. In: Feigin RD, Cherry JD, editors. Textbook of pediatric infectious diseases. 4 ed. Philadelphia: WB Saunders Company; 1998.p.489.
49. Weir M, Brien J. Adolescent urinary tract infections. Adolesc Med 2000;11:293-313.
50. Krieger JN. Urinary tract infections: what's new? J Urol 2002;168:2351-8.